NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

But many analysts point out that the organization creates serious problems. For example, the approval process for new drugs is notoriously slow, gives big drug companies an edge, reduces innovation, and increases drug prices. Many life-saving drugs never make it to market.

The FDA’s track record for safety is likewise questionable. The agency has recalled dozens of drugs after approving them, some of which had been on the market for over 50 years.

There’s an alternative. Instead of relying on a clunky bureaucracy, let’s leave the product safety to competing private firms. The marketplace should determine what products are best for consumers.

It's no secret - even to FDA Commissioners -- that the agency is slow, or as describe in the attached article, as "clunky."

http://www.independent.org/newsroom/article.asp?id=8654